Bookbot
Exactement cet exemplaire ira dans le panier

Handbook of Hypertension - 24: Genetics of Hypertension

Paramètres

  • 283pages
  • 10 heures de lecture

En savoir plus sur le livre

Classic and modern tools of genetics have been applied to hypertension research for some 20 years. This volume in the Handbook of Hypertension series aims to go beyond a simple summary of discoveries and provides a critical commentary on many controversial issues. It will be particularly useful for clinician scientists at all stages of their careers, graduate students and post-doctoral scientists as well as all those interested in cardiovascular medicine and research throughout the entire spectrum from bench to bedside. As in every relatively young area of research, the initial excitement over the early positive observations has not always been confirmed by subsequent larger studies with greater statistical power. Issues related to current recommendations on design of studies and their analysis are therefore included. Pharmacogenetics and pharmacogenomics have been the subjects of many debates in recent years and are of particular importance in hypertension as life-long treatments, frequently with multiple drugs are given to millions of people world-wide. A critical appraisal of this controversial topic is provided. Several chapters on experimental genetics of hypertension with a special focus on physiological genomics are also included.

Achat du livre

Handbook of Hypertension - 24: Genetics of Hypertension, W. H. Birkenhäger, Anna F. Dominiczak, J. L. Reid, John M. C. Connell

Langue
Année de publication
2007
Reliure
(rigide),
État du livre
Très bon
Prix
76,39 €

Modes de paiement

Personne n'a encore évalué .

Titre
Handbook of Hypertension - 24: Genetics of Hypertension
Langue
Anglais
Éditeur
Elsevier
Publié
2007
Format
rigide
Pages
283
ISBN10
0444514562
ISBN13
9780444514561
Séries
Description
Classic and modern tools of genetics have been applied to hypertension research for some 20 years. This volume in the Handbook of Hypertension series aims to go beyond a simple summary of discoveries and provides a critical commentary on many controversial issues. It will be particularly useful for clinician scientists at all stages of their careers, graduate students and post-doctoral scientists as well as all those interested in cardiovascular medicine and research throughout the entire spectrum from bench to bedside. As in every relatively young area of research, the initial excitement over the early positive observations has not always been confirmed by subsequent larger studies with greater statistical power. Issues related to current recommendations on design of studies and their analysis are therefore included. Pharmacogenetics and pharmacogenomics have been the subjects of many debates in recent years and are of particular importance in hypertension as life-long treatments, frequently with multiple drugs are given to millions of people world-wide. A critical appraisal of this controversial topic is provided. Several chapters on experimental genetics of hypertension with a special focus on physiological genomics are also included.